批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 1989/05/25 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
;Orphan
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2025/10/08 |
SUPPL-38(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2024/10/10 |
SUPPL-37(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2023/12/08 |
SUPPL-36(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2023/08/16 |
SUPPL-35(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2023/02/17 |
SUPPL-34(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2023/02/10 |
SUPPL-33(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2022/01/29 |
SUPPL-30(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2021/10/21 |
SUPPL-29(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2021/06/17 |
SUPPL-28(补充) |
Approval |
Labeling-Patient Package Insert |
STANDARD
|
|
|
| 2020/05/12 |
SUPPL-27(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2019/08/27 |
SUPPL-25(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2019/02/28 |
SUPPL-23(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2019/01/23 |
SUPPL-21(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2018/01/08 |
SUPPL-20(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2017/04/24 |
SUPPL-17(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. |
| 2015/12/02 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2015/04/09 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2013/02/27 |
SUPPL-14(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2010/11/10 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2004/08/20 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2000/04/12 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2000/04/12 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 1996/09/17 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 1995/07/28 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1993/06/18 |
SUPPL-1(补充) |
Approval |
Labeling |
;Orphan
|
|
|
| 1992/03/10 |
SUPPL-2(补充) |
Approval |
Labeling |
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:RIFAMPIN; 剂型/给药途径:INJECTABLE;INJECTION; 规格:600MG/VIAL; 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 050627 |
001 |
NDA |
RIFADIN |
RIFAMPIN |
INJECTABLE;INJECTION |
600MG/VIAL |
Prescription |
Yes |
Yes |
AP |
1989/05/25
|
SANOFI AVENTIS US |
| 064217 |
001 |
ANDA |
RIFAMPIN |
RIFAMPIN |
INJECTABLE;INJECTION |
600MG/VIAL |
Prescription |
No |
No |
AP |
1999/10/29
|
HIKMA |
| 065421 |
001 |
ANDA |
RIFAMPIN |
RIFAMPIN |
INJECTABLE;INJECTION |
600MG/VIAL |
Prescription |
No |
No |
AP |
2008/05/22
|
MYLAN LABS LTD |
| 065502 |
001 |
ANDA |
RIFAMPIN |
RIFAMPIN |
INJECTABLE;INJECTION |
600MG/VIAL |
Prescription |
No |
No |
AP |
2010/09/21
|
EPIC PHARMA LLC |
| 091181 |
001 |
ANDA |
RIFAMPIN |
RIFAMPIN |
INJECTABLE;INJECTION |
600MG/VIAL |
Prescription |
No |
No |
AP |
2014/08/21
|
FRESENIUS KABI USA |
| 205039 |
001 |
ANDA |
RIFAMPIN |
RIFAMPIN |
INJECTABLE;INJECTION |
600MG/VIAL |
Prescription |
No |
No |
AP |
2016/03/03
|
HIKMA PHARMS |